Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2014
04/15/2014US8697717 Inhibitors of histone deacetylase
04/15/2014US8697706 Compounds for the treatment of hepatitis C
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/15/2014US8697640 Method for treating fungal infection with antifungal bifunctional molecules
04/15/2014US8697637 Antimicrobial peptides of the cecropin family and therapeutic uses thereof
04/15/2014US8697104 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
04/15/2014US8697069 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells
04/15/2014US8697061 Tumor specific oligosaccharide epitopes and use thereof
04/15/2014US8697055 Probiotic, lactic acid-producing bacteria
04/15/2014CA2764134C Compositions and methods for preventing sternal wound infections
04/15/2014CA2436208C A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
04/15/2014CA2399298C Use of il-18 inhibitors
04/10/2014WO2014055944A1 Small molecules as anti-hiv agents that disrupt vif self-association and methods of use thereof
04/10/2014WO2014055938A1 Novel compounds, their preparation and their uses
04/10/2014WO2014055624A1 Methods relating to dna-sensing pathway related conditions
04/10/2014WO2014055618A1 Solid state forms of hiv inhibitor: hemi-succinate of (2s)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid)
04/10/2014WO2014055474A1 Mannose derivatives for treating bacterial infections
04/10/2014WO2014055289A1 Immunization with rabies virus vector expressing foreign protein antigen
04/10/2014WO2014055142A1 Inhibitors of hepatitis c virus polymerase
04/10/2014WO2014055127A1 Methods of inhibiting surface attachment of microorganisms
04/10/2014WO2014053977A1 Natural antiseptic solution to be used as teat dip (dipping) during milking for prevention and control of mastitis
04/10/2014WO2014053873A1 Polymeric prodrug conjugates
04/10/2014WO2014053666A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/10/2014WO2014053665A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/10/2014WO2014053642A1 Use of glycerophosphoinositols for the treatment of septic shock
04/10/2014WO2014053595A1 Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
04/10/2014WO2014053516A1 1,2,4-triazine derivatives for the treatment of viral infections.
04/10/2014WO2014053482A1 Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
04/10/2014WO2014053481A1 Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza
04/10/2014WO2014053246A1 Vaccination against japanese encephalitis, measles, mumps and rubella
04/10/2014WO2014016613A3 Type b lantibiotic nvb302 for the treatment of c. difficile infection
04/10/2014US20140100238 Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
04/10/2014US20140099339 Vaccine against streptococcus pneumoniae
04/10/2014US20140099296 Topically or orally applied aloe, distilled water, sodium chloride, and lysozyme mixture and method of producing the mixture
04/09/2014EP2716757A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain
04/09/2014EP2716752A1 Canine influenza recombinant virus, preparation method therefor and application thereof
04/09/2014EP2716749A1 Strain of cobetia marina and biosurfactant extract obtained from same
04/09/2014EP2716661A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof
04/09/2014EP2716656A1 Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
04/09/2014EP2716653A1 Truncated human papillomavirus type 33 protein l1
04/09/2014EP2716647A2 Macrocyclic compounds and methods of making and using the same
04/09/2014EP2716639A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/09/2014EP2716632A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/09/2014EP2716289A1 Wound and mucous membrane antiseptic based on Bispyridiniumalkanes
04/09/2014EP2714904A2 Oligonucleotides for modulation of target rna activity
04/09/2014EP2714716A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
04/09/2014EP2714693A2 Anti-viral compounds
04/09/2014EP2714661A1 Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
04/09/2014EP2714654A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
04/09/2014EP2714636A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
04/09/2014EP2714045A1 Pharmaceutical antiretroviral composition
04/09/2014EP2714036A2 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
04/09/2014EP2714035A2 Anti-viral compounds
04/09/2014EP2714026A2 Modulation of the ubiquitin-proteasome system (ups)
04/09/2014EP2714021A1 Composition of monoterpenoids having bactericidal properties
04/09/2014EP2714010A2 Topical pharmaceutical composition based on semifluorinated alkanes
04/09/2014EP2714008A2 Pharmaceutical composition for administration to nails
04/09/2014EP2713729A2 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
04/09/2014CN203524979U Multipurpose warming moxibustion bag
04/09/2014CN103717607A Cefuroxime sodium crystal compound and composition powder injection thereof
04/09/2014CN103717589A Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
04/09/2014CN103717240A Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
04/09/2014CN103717227A Clostridium difficile growth inhibitor
04/09/2014CN103717212A A topical formulation for treatment of hyperkeratotic skin
04/09/2014CN103710418A Method for inhibiting Aspergillus fumigatus biofilm from formation
04/09/2014CN103710384A Picornaviridae recombinant vector, virus like particle, and preparation method and use of virus like particle
04/09/2014CN103710345A Small non-coding RNA (ribonucleic acid) molecule BSR0601 from Brucella melitensis and application thereof
04/09/2014CN103710314A Avian Encephalomyelitis virus attenuated vaccine strain
04/09/2014CN103710313A Newcastle disease virus strain H12 and application thereof to preparation of Newcastle disease attenuated live vaccine
04/09/2014CN103710232A Agrimony healthcare wine for bacillary dysentery
04/09/2014CN103710177A Patchouli essential oil handmade soap for removing comedos and acnes and fabrication method thereof
04/09/2014CN103709280A Mucoadhesive polymers having vitamin B partialstructures
04/09/2014CN103709250A Human monoclonal antibodies against CD20
04/09/2014CN103709249A Antibodies and methods for making and using them
04/09/2014CN103709247A Divalent egg yolk antibodies of type I and novel duck hepatitis as well as preparation method and application thereof
04/09/2014CN103709232A Polypeptide capable of inhibiting human immunodeficiency virus infection activity, and related bacteriophage
04/09/2014CN103709222A 7-deazapurine ribonucleoside compounds, and synthesis method and medical application thereof
04/09/2014CN103709220A 3-methyluridine and 4-methylcytidine nucleosides compound and synthesis method and pharmaceutical application thereof
04/09/2014CN103709177A Rifamycin and valnemulin hybrid antibiotic and preparation method thereof
04/09/2014CN103709151A Spiro compounds adopted as hepatitis C inhibitor, and applications of spiro compounds in preparation of drugs
04/09/2014CN103709122A Antitumor and antifungal compound for treatment
04/09/2014CN103709115A Pleuromutilin antibiotic derivatives
04/09/2014CN103709102A Spiro ring-containing pleuromutilin antibiotics
04/09/2014CN103709093A Combined-ring-containing pleuromutilin antibiotics
04/09/2014CN103709085A Pleuromutilin antibiotics
04/09/2014CN103709083A Benzaldehyde thiosemicarbazone derivative and application
04/09/2014CN103709077A Benzaldehyde semicarbazide derivative and application thereof
04/09/2014CN103709064A Benzyl dialdehyde reduced aminobenzoic acid derivative and application
04/09/2014CN103709063A Benzaldehyde reduced aminobenzoic acid derivative and application
04/09/2014CN103709062A Benzaldehyde reduced glycine derivative and application
04/09/2014CN103705942A Antimicrobial compositions
04/09/2014CN103705935A Heat-proof freeze-dried protective agent and preparation method and application thereof
04/09/2014CN103705932A Polylactic acid-polyethylene glycol coated florfenicol nanofiber and preparation method thereof
04/09/2014CN103705918A Porcine epidemic diarrhea virus resistant hyper-immune serum and preparation method thereof
04/09/2014CN103705917A M2e synthetic peptide swine influenza virus general vaccine and application
04/09/2014CN103705916A Vaccine of encephalomyelitis of poultry
04/09/2014CN103705914A Staphylococcus aureus vaccine and preparation method thereof
04/09/2014CN103705912A Composite lysozyme oral spray and preparation method thereof
04/09/2014CN103705908A Lyophilized pharmaceutical composition containing thymopentin and preparation method thereof
04/09/2014CN103705883A Medicine for treating skin diseases and preparation
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 1798